Haisco (002653.SZ): Innovative Drug HSK42360-Na Tablets Included in Breakthrough Therapy Drug Program

Zhitong Finance APP News, Haisco (002653.SZ) announced that the company learned on September 24, 2026 that HSK42360-Na tablets have been officially included by the Center for Drug Evaluation (CDE) of the National Medical Products Administration in the "Breakthrough Therapy Designation List," which will greatly advance the research and development process of new drugs in this field and bring new hope for the treatment of glioma patients in China.